United States Biotechnology & Medical Research

Ensysce Biosciences Inc (ENSC)

Track

Track

Ensysce Biosciences recorded one notable purchase of 400,000 shares valued at $198,000 by Bob G. Gower on August 7, 2026. This transaction occurred shortly before the latest results financiers, where the firm outperformed expectations by 60%. The stock has gained 33.9% over the past quarter despite trading near its annual low.
Ticker: ENSC Exchange: NAS
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for Ensysce Biosciences Inc. Upgrade to see score, net flow, insiders and the full signal context.

Open in Activity Signals screener →
Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
1.1
GOWER BOB G Non-Executive Director
Transaction date
Purchase
Price
159.42
Quantity 52,104 +32.3%
Value US$2,793,119
1.1
GOWER BOB G Non-Executive Director
Transaction date
Purchase
Price
416.78
Quantity 26,511 +14.5%
Value US$3,196,627
1.1
GOWER BOB G Non-Executive Director
Transaction date
Purchase
Price
120.09
Quantity 22,970 -37.1%
Value US$2,601,361
1.1
GOWER BOB G Non-Executive Director
Transaction date
Purchase
Price
0.48
Quantity 270,000 +31.3%
Value US$128,979
1.1
GOWER BOB G Non-Executive Director
Transaction date
Purchase
Price
0.49
Quantity 109,300 +14.5%
Value US$53,371
1.1
GOWER BOB G Non-Executive Director
Transaction date
Purchase
Price
1.40
Quantity 357,143 +90.2%
Value US$500,000
1.0
Kirkpatrick Lynn Chief Executive Officer Executive Director
Transaction date
Purchase
Price
0.53
Quantity 27,000 +7.6%
Value US$14,216
1.0
Kirkpatrick Lynn Chief Executive Officer Executive Director
Transaction date
Purchase
Price
0.49
Quantity 70,000 +24.6%
Value US$34,083
0.7
MORGAN STANLEY Large shareholder
Transaction date
Sale
Price
0.00
Quantity 776,290
Value US$0
HG Vora Capital Management, LLC Large shareholder
Transaction date
Purchase
Price
10.00
Quantity 1,000,000 +35.2%
Value US$10,000,000
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2026-08-18 2026-08-07 B Purchase
1.1
GOWER BOB G
Non-Executive Director
52,104 +32.3%
159.42
US$2,793,119 		52,104 +32.3% 159.42 US$2,793,119
2026-08-18 2026-04-23 B Purchase
1.1
GOWER BOB G
Non-Executive Director
26,511 +14.5%
416.78
US$3,196,627 		26,511 +14.5% 416.78 US$3,196,627
2023-03-06 2023-03-02 B Purchase
1.1
GOWER BOB G
Non-Executive Director
22,970 -37.1%
120.09
US$2,601,361 		22,970 -37.1% 120.09 US$2,601,361
2023-03-02 2023-03-01 B Purchase
1.1
GOWER BOB G
Non-Executive Director
270,000 +31.3%
0.48
US$128,979 		270,000 +31.3% 0.48 US$128,979
2023-03-02 2023-02-28 B Purchase
1.1
GOWER BOB G
Non-Executive Director
109,300 +14.5%
0.49
US$53,371 		109,300 +14.5% 0.49 US$53,371
2023-02-01 2022-12-09 B Purchase
1.1
GOWER BOB G
Non-Executive Director
357,143 +90.2%
1.40
US$500,000 		357,143 +90.2% 1.40 US$500,000
2022-05-27 2022-05-26 B Purchase
1.0
Kirkpatrick Lynn

Chief Executive Officer

Executive Director
27,000 +7.6%
0.53
US$14,216 		27,000 +7.6% 0.53 US$14,216
2022-05-27 2022-05-25 B Purchase
1.0
Kirkpatrick Lynn

Chief Executive Officer

Executive Director
70,000 +24.6%
0.49
US$34,083 		70,000 +24.6% 0.49 US$34,083
2020-06-23 2020-06-19 S Sale
0.7
MORGAN STANLEY
Large shareholder
776,290
0.00
US$0 		776,290 0.00 US$0
2018-01-17 2017-12-01 B Purchase HG Vora Capital Management, LLC Large shareholder
1,000,000 +35.2%
10.00
US$10,000,000 		1,000,000 +35.2% 10.00 US$10,000,000
Explore more

More insider trading research around Ensysce Biosciences Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America